<DOC>
	<DOCNO>NCT02086526</DOCNO>
	<brief_summary>The investigator 's global hypothesis woman Polycystic Ovary Syndrome ( PCOS ) separate subtypes base response metformin . The investigator propose use target non-targeted metabolomic approach identify pathway associate metformin 's effect insulin sensitivity endothelial function . This pilot project foundation develop tailor therapeutic approach Polycystic Ovary Syndrome identify novel drug target .</brief_summary>
	<brief_title>Targeting Pathways Polycystic Ovary Syndrome ( PCOS ) Using Metformin ( MET )</brief_title>
	<detailed_description>The investigator propose use target non-targeted metabolomic approach identify pathway associate metformin 's effect insulin sensitivity , weight , androgens endothelial function . This project foundation develop tailor therapeutic approach Polycystic Ovary Syndrome identify novel drug target . This pilot project intend inform development hypothesis specific aim future grant application National Institutes Health ( NIH ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion : Body mass index ( BMI ) great equal 25 Polycystic Ovary Syndrome criterion oligomenorrhea ( &lt; 9 menses per year ) androgen excess [ clinical hirsutism ( FerrimanGallway score &gt; 8 severe acne ) elevate testosterone ] . Taking medication treatment insulin resistance . Exclusion : Diagnosis Cushing 's syndrome Untreated hypo/hyperthyroidism Elevated prolactin Congenital adrenal hyperplasia Renal insufficiency ( creatinine &gt; 1.5 ) Diabetes Medications significantly affect endothelial function Pregnancy Breast Feeding Taking oral contraceptive Currently smoke</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>